Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/1991
05/02/1991WO1991005803A1 Recombinant human thrombomodulin
05/02/1991WO1991005802A1 Osteogenic devices
05/02/1991WO1991005800A1 ANTI-RhD HETEROANTIBODIES AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
05/02/1991WO1991005798A1 Compositions and methods for treating or preventing infections in canine and feline animals
05/02/1991WO1991005795A1 Stem cell factor
05/02/1991WO1991005763A1 Dipeptide-analog-based metalloendopeptidase inhibitors and methods of using same
05/02/1991WO1991005571A1 Method for producing bone marrow growth cell factors
05/02/1991WO1991005566A1 Protease nexin i/dextran sulfate anticoagulant
05/02/1991WO1991005562A1 Anti-thrombotic peptides and pseudopeptides
05/02/1991WO1991005555A2 N-acyl peptide metalloendopeptidase inhibitors and methods of using same
05/02/1991WO1990013306A3 Small polypeptides
05/02/1991EP0425235A2 Cytotoxic agents comprising maytansinoids and their therapeutic use
05/02/1991EP0425212A2 Cyclic anti-aggregatory peptides
05/02/1991EP0425096A1 Polypeptides useful as blockers of calcium channels
05/02/1991EP0425082A1 Bordetella vaccines
05/02/1991EP0425019A1 Methods and compositions employing certain lysozymes and endoglycosidases
05/02/1991EP0424990A1 The manufacture and expression of large structural genes
05/02/1991EP0424954A1 Pharmaceutical composition for treatment of osteoporosis
05/02/1991EP0424748A1 Synthetic envelope peptides of HTLV-I
05/02/1991EP0424670A1 ZNS-active hexapeptides with antiamnestic activity
05/02/1991EP0424484A1 Novel bacteriocin compositions for use as enhanced broad range bactericides and methods of preventing and treating microbial infection.
05/02/1991EP0424470A1 Method for using protease inhibitors to treat and/or prevent pancreatitis
05/02/1991EP0424386A1 Device for site directed neovascularization and method for same
05/02/1991EP0214232B1 Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known and methods of design therefor
05/02/1991EP0205564B1 Method for the production of erythropoietin
05/02/1991CA2067235A1 Modified biological material
05/02/1991CA2042577A1 Osteogenic devices
05/02/1991CA2029018A1 Analogues of gonadotropin releasing hormone
05/01/1991WO1991006573A1 Inhibitor of laminin neurite promoting activity
05/01/1991WO1991006543A1 GnRH ANALOGS
05/01/1991WO1991006308A1 A casein fraction for therapeutic, profylactic and/or diagnostic use in infections of the respiratory tract
05/01/1991CA2066658A1 Inhibitor of laminin neurite promoting activity
05/01/1991CA2066184A1 Gnrh analogs
05/01/1991CA2044244A1 Antibacterial composition
05/01/1991CA2026686A1 Method for preventing onset of type ii diabetes employing an ace inhibitor
04/1991
04/30/1991US5011952 Phospholipase A2 inhibitor
04/30/1991US5011914 Purified ciliary neurotrophic factor
04/30/1991US5011825 Treatment of hypertension, diabetes, edema
04/30/1991US5011824 Rectal motilin preparation
04/30/1991US5011778 Medicament for blocking inflammatory responses
04/30/1991US5011777 Vectors encoding brain derivable polypeptide factors
04/30/1991US5011773 Human esterase D, its uses and a process of purification
04/30/1991US5011691 Protein from DNA expression, a pair of polypeptide chains; implanting to induce endochondral bone formation in mammals
04/30/1991US5011687 Purified Mullerian inhibiting substance and process for treating human ovarian cancer cells
04/30/1991US5011684 Administering monoclonal antibody to interleukin receptor
04/30/1991CA2001756A1 New human lymphotoxin n-end deletion mutant
04/30/1991CA1283661C Imidazolides, process for their preparation and application as intermediates for the synthesis of cytotoxic conjugates
04/29/1991CA2028665A1 Bioavailability of pharmaceutical active compounds with peptide linkages
04/28/1991WO1991006650A1 C1 inhibitor muteins and uses thereof
04/28/1991WO1991006564A1 hPTH (1-37) FRAGMENT, ITS PRODUCTION, DRUG CONTAINING IT AND ITS USE
04/28/1991WO1991006561A1 Method for treating hiv and other retroviruses and compounds useful therefor
04/28/1991WO1991006320A1 Compositions containing plant-produced glycopolypeptide multimers, multimeric proteins, and their use
04/28/1991CA2071871A1 C1 inhibitor muteins and uses thereof
04/28/1991CA2071502A1 Compositions containing plant-produced glycopolypeptide multimers, multimeric proteins, and their use
04/28/1991CA2066644A1 Method for treating hiv and other retroviruses and compounds useful therefor
04/28/1991CA2028517A1 Enhancement of porcine somatotropin activity
04/27/1991WO1991006302A1 Ribozyme inhibitors
04/27/1991CA2071534A1 Ribozyme inhibitors
04/25/1991WO1991006647A1 Gastrin releasing peptide receptor
04/25/1991WO1991006646A1 Solubilization and purification of the gastrin releasing peptide receptor
04/25/1991CA2069965A1 Solubilization and purification of the gastrin releasing peptide receptor
04/25/1991CA2067821A1 Infective drug delivery system using recombinant retroviral vectors
04/25/1991CA2067766A1 Gastrin releasing peptide receptor
04/25/1991CA2028188A1 Method for the prevention and treatment of bovine mastitis
04/24/1991WO1991005799A1 Polypeptide inhibitors of gamma interferon
04/24/1991EP0424351A2 Modified heparin cofactor II
04/24/1991EP0424318A1 Process for preparing protease inhibitors
04/24/1991EP0424107A1 A novel tumor-associated antigen
04/24/1991EP0424051A1 Glycopeptide antibiotics
04/24/1991EP0424033A2 External skin preparation
04/24/1991EP0423980A1 Stem cell factor
04/24/1991EP0423869A1 Infectious bronchitis virus vaccine
04/24/1991EP0423845A1 A synthetic gene encoding gamma-interferon
04/24/1991EP0423747A2 Glycosyl-etoposide prodrugs, process for their preparation and their use in combination with functionalised tumour-specific enzyme conjugates
04/24/1991EP0423649A1 Peptides and use thereof
04/24/1991EP0423641A2 Expression vector, transformed microorganism, fusion protein and method for the production of platelet factor 4 or TGFalpha
04/24/1991EP0423419A1 Inhibitive agent against activity of alpha-amylase
04/24/1991EP0423358A1 Postostatin and related compound thereof, or their salts
04/24/1991EP0423326A1 Novel physiologically active peptide and calcium metabolism-regulating agent comprising said peptide as effective ingredient
04/24/1991EP0423322A1 Grf analogs viia.
04/24/1991EP0423317A1 Invasive microorganisms
04/24/1991EP0423262A1 Protein fraction from the photosynthesis apparatus of plants for use as an active substance in the selective destruction of cancer cells and the post-treatment of scars, keloids and inflammatory processes and pharmaceutical products containing it.
04/24/1991EP0423252A1 Tumour necrosis factor muteins
04/24/1991EP0423239A1 Post-transfusion, non-a, non-b hepatitis virus and antigens
04/24/1991EP0423236A1 Peptides with extraordinary opioid receptor selectivity
04/24/1991EP0423207A1 A migration stimulating factor
04/24/1991EP0423193A1 A method of treating diseases caused by immunodeficiency states by administering human neutrophil chemotactic factor to human
04/24/1991EP0423191A1 Treatment of genital warts with a combination of podophyllin and recombinant dna human alpha interferon
04/24/1991CN1050899A Novel entities for cancer therapy
04/24/1991CA2070416A1 Polypeptide inhibitors of gamma interferon
04/24/1991CA2028172A1 Synthetic envelope peptides of htlv-i
04/24/1991CA2026642A1 Method for stabilizing or causing regression of atherosclerosis in coronary arteries employing an ace inhibitor
04/24/1991CA2026602A1 Method for rehabilitating the vasorelaxant action of the coronary arteries impaired through atherosclerosis or hypercholesterolemia employing an ace inhibitor
04/23/1991US5010174 Novel calcitonin derivative and salt thereof
04/23/1991US5010167 Poly(amide-and imide-co-anhydride) for biological application
04/23/1991US5010097 Collagenase inhibitors, antiarthritic agents
04/23/1991US5010089 CCK antagonists and their use in treating gastrointestinal disorders
04/23/1991US5010057 Renin-inhibiting peptides having an aminomethyl side chain
04/23/1991US5010056 Pharmaceutical composition for intranasal administration, comprising GH-releasing hormone, a cholinergic agonist and optionally a bile salt
04/23/1991US5010055 Glycoprotein hormones and peptide hormones; controlling fertility
1 ... 3010 3011 3012 3013 3014 3015 3016 3017 3018 3019 3020 3021 3022 3023 3024 3025 3026 3027 3028 3029 3030 ... 3163